Scientist in the lab at Gladstone Institutes (IMAGE)
Caption
Researchers at Gladstone Institutes designed a new platform for studying how the human immune system responds to hepatitis C infection by combining microfluidic technology with liver organoids.
Credit
Photo: Michael Short/Gladstone Institutes
Usage Restrictions
Use for non-commercial purposes only, in relation to this study
License
Original content